Ellipsis Health
Founded Year
2017Stage
Series A | AliveTotal Raised
$30.29MLast Raised
$26M | 2 yrs agoAbout Ellipsis Health
Ellipsis Health develops artificial intelligence (AI) generated vocal biomarker technology helping in identifying, assessing, and monitoring mental health. With a short voice sample, its technology determines the severity of anxiety and depression. Ellipsis Health was founded in 2017 and is based in San Francisco, California.
Ellipsis Health's Product Videos
Compete with Ellipsis Health?
Ensure that your company and products are accurately represented on our platform.
Ellipsis Health's Products & Differentiators
VOCAI
Vocai, Ellipsis Health's voice-powered AI tool, detects depression & anxiety during calls and telemedicine sessions supporting the following: Early Detection for Quick Triage Vocai passively analyzes patient voice in real-time and provides risk scores to providers, identifying costly patients who are falling through the cracks. Triage to Mental Health Support Vocai directly connects higher-risk members to mental health professionals. Lower-risk members are matched with evidence-based preventative care. Plugs into your existing call software Vocai works across all channels - our API and SDKs provide flexible integration wherever your providers work. Mental Health Monitoring Use Vocai to gather and analyze patient and population health data and facilitate value-based care. You can access VOCAI here: https://vocai.ai/
Research containing Ellipsis Health
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Ellipsis Health in 2 CB Insights research briefs, most recently on Dec 7, 2022.
Expert Collections containing Ellipsis Health
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Ellipsis Health is included in 10 Expert Collections, including Mental Health Tech.
Mental Health Tech
1,410 items
This collection includes companies applying technology to problems of emotional, psychological, and social well-being. Examples include companies working in areas such as substance abuse, eating disorders, stress reduction, depression, PTSD, and anxiety.
Artificial Intelligence
10,622 items
This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.
Medical Devices
8,633 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Digital Health
10,069 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma companies and and assistive tech developers.
Telehealth
2,856 items
Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.
Health Monitoring & Diagnostics
987 items
Companies offering smartphone-based health monitoring & diagnostic solutions (using native components of the smartphone, e.g. camera, microphone, accelerometer, gyroscope, etc.). Companies tagged as #SmartphoneBasedDiagnostics
Ellipsis Health Patents
Ellipsis Health has filed 9 patents.
The 3 most popular patent topics include:
- Psychiatric diagnosis
- Mood disorders
- Clinical psychology tests
Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
12/21/2020 | 9/14/2021 | Natural language processing, Psychiatric diagnosis, Computational linguistics, Abnormal psychology, Mood disorders | Grant |
Application Date | 12/21/2020 |
---|---|
Grant Date | 9/14/2021 |
Title | |
Related Topics | Natural language processing, Psychiatric diagnosis, Computational linguistics, Abnormal psychology, Mood disorders |
Status | Grant |
Latest Ellipsis Health News
Mar 29, 2023
March 29, 2023 The Healthcare Technology Report is pleased to announce The Top 25 Women Leaders in Biotechnology of 2022. The COVID-19 pandemic saw an explosion in biotech funding in 2020 and 2021. And while that funding has declined somewhat this year, the added attention the industry has received means funding will likely never return to its previous levels... The awardees on this year’s list represent the absolute best in the healthcare technology space. From companies like Novartis with more than 100,000 team members around the globe, to numerous smaller startups with just a few dozen employees in a single office, these companies are changing the face of the industry... The costly process of genome sequencing is getting a price cut thanks to genetic variation and biological function analysis solutions company Illumina. Illumina’s HiSeq x Ten Machine dropped the price of sequencing a genome to $1,000 in 2014, and now the company claims its two-pronged NovaSeq X Series machines... The Healthcare Technology Report is pleased to announce The Top 25 Women Leaders in Consumer HealthTech of 2022. The awardees on this year’s list represent some of the most innovative companies in the healthcare technology space. They provide their organizations with steady leadership and deep knowledge in their respective specialties, piloting their companies through ever-changing market conditions... The Healthcare Technology Report is pleased to announce The Top 100 Healthcare Technology Companies of 2021. This year’s awardees comprise a broad range of companies from well-known names like Johnson & Johnson, 3M Health Care, and Illumia to relatively newer but rapidly growing enterprises such as GRAIL, Capsule, and DNA Script... Finding results in a space where its rivals have consistently fallen short, British drugmaker AstraZeneca (AZ) is proudly touting the success of two of its experimental breast cancer drugs in separate clinical trials. The first, capivasertib, rose to meet both of its goals in a phase-3 trial consisting of breast cancer patients... A new mental health-focused partnership between Ellipsis Health and Ceras Health aims at empowering real-time severity scores of anxiety and depression in an effort to support patient care. Ellipsis, a large presence in AI-powered human voice biomarker tech, will integrate its processes into the Ceras’ clinical monitoring platform... The Healthcare Technology Report is pleased to announce The Top 25 Women Leaders in Medical Devices of 2022. With the medical device industry advancing at an unprecedented rate, new and exciting developments in robotics, materials science, analytics, and other technologies have accelerated the production of breakthrough devices that are improving outcomes for patients... The Healthcare Technology Report is your comprehensive source for business news, investment activity and corporate actions related to the healthcare technology industry.
Ellipsis Health Frequently Asked Questions (FAQ)
When was Ellipsis Health founded?
Ellipsis Health was founded in 2017.
Where is Ellipsis Health's headquarters?
Ellipsis Health's headquarters is located at 118 2nd Street, San Francisco.
What is Ellipsis Health's latest funding round?
Ellipsis Health's latest funding round is Series A.
How much did Ellipsis Health raise?
Ellipsis Health raised a total of $30.29M.
Who are the investors of Ellipsis Health?
Investors of Ellipsis Health include Able Partners, Helmy Eltoukhy, Joanne Bradford, Khosla Ventures, Alumni Ventures and 17 more.
Who are Ellipsis Health's competitors?
Competitors of Ellipsis Health include Winterlight Labs, Mindwell Labs, Feel Therapeutics, Deliberate AI, Aural Analytics and 11 more.
What products does Ellipsis Health offer?
Ellipsis Health's products include VOCAI and 1 more.
Who are Ellipsis Health's customers?
Customers of Ellipsis Health include Cigna International, Headspace and Ceras Health.
Compare Ellipsis Health to Competitors
Kintsugi develops and offers smarter mental healthcare infrastructure using voice biomarkers to streamline access to care. It detects signs of clinical depression and anxiety using machine learning and voice biomarkers. The company was founded in 2019 and is based in Berkeley, California.
Sonde Health is a health technology company that provides voice-enabled symptom detection and monitoring platform for chronic and mental health conditions. The platform analyzes vocal features that reflect changes in a user's voice caused by changing physiology of their body due to symptoms of the disease. The company was founded in 2015 and is based in Boston, Massachusetts.
Aural Analytics uses speech to detect subtle but clinically meaningful changes in brain health. The platform is completely agnostic to disease, device, location and language and powers applications throughout the world. Aural Analytics was founded in 2015 and is based in Scottsdale, Arizona.
Modality.AI detects health conditions using conversational AI. The company's platform analyzes the video of a user, recorded while the user interacts with an on-screen avatar, for facial movements and speech patterns to evaluate changes in neurological diseases to assess neurological and psychiatric states. Its platform can be used in clinics by physicians or as a point-of-care at home. It was founded in 2018 and is based in San Francisco, California.
Vocalis Health is a vocal biomarker company using voice to detect, diagnose, and monitor patient health. Its technology leverages machine learning (ML) and deep learning (DL) techniques to analyze voice recordings for insights regarding various health conditions via a mobile application and web browser. The company was founded in 2019 and is based in Newton, Massachusetts.
Deliberate AI develops and provides a data analytics platform that utilizes AI-based algorithms to provide diagnostics, monitoring, and data insights for mental and neurological healthcare and clinical trials. Its platform is used by clinicians, physicians, and healthcare researchers. It was founded in 2020 and is based in New York, New York.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.